Exempt Offering Notice · D
Lisata Therapeutics, Inc.
LSTANASDAQEQUITYCurrent
Exempt Offering Notice
Structured filing — D
primary_doc.xml
Issuer
- Name
- LISATA THERAPEUTICS, INC.
- CIK
- 0000320017
- Entity type
- Corporation
- Jurisdiction
- DELAWARE
- Phone
- 908-229-2590
- Street
- 110 ALLEN ROAD
- Street (continued)
- SECOND FLOOR
- City
- BASKING RIDGE
- State / country code
- NJ
- State / country
- NEW JERSEY
- Postal code
- 07920
- Incorporated more than five years ago
- true
- Previous EDGAR names
- CALADRIUS BIOSCIENCES, INC. · Caladrius Biosciences, Inc. · NeoStem, Inc.
Related person 1
- First name
- DAVID
- Last name
- MAZZO
- Relationships
- Executive Officer · Director
- Relationship clarification
- [blank]
- Street
- 110 ALLEN ROAD
- Street (continued)
- SECOND FLOOR
- City
- BASKING RIDGE
- State / country code
- NJ
- State / country
- NEW JERSEY
- Postal code
- 07920
Related person 2
- First name
- JAMES
- Last name
- NISCO
- Relationships
- Executive Officer
- Relationship clarification
- [blank]
- Street
- 110 ALLEN ROAD
- Street (continued)
- SECOND FLOOR
- City
- BASKING RIDGE
- State / country code
- NJ
- State / country
- NEW JERSEY
- Postal code
- 07920
Related person 3
- First name
- TARIQ
- Last name
- IMAM
- Relationships
- Executive Officer
- Relationship clarification
- [blank]
- Street
- 110 ALLEN ROAD
- Street (continued)
- SECOND FLOOR
- City
- BASKING RIDGE
- State / country code
- NJ
- State / country
- NEW JERSEY
- Postal code
- 07920
Related person 4
- First name
- GREGORY
- Last name
- BROWN
- Relationships
- Director
- Relationship clarification
- [blank]
- Street
- 110 ALLEN ROAD
- Street (continued)
- SECOND FLOOR
- City
- BASKING RIDGE
- State / country code
- NJ
- State / country
- NEW JERSEY
- Postal code
- 07920
Related person 5
- First name
- HEIDI
- Last name
- HENSON
- Relationships
- Director
- Relationship clarification
- [blank]
- Street
- 110 ALLEN ROAD
- Street (continued)
- SECOND FLOOR
- City
- BASKING RIDGE
- State / country code
- NJ
- State / country
- NEW JERSEY
- Postal code
- 07920
Related person 6
- First name
- CYNTHIA
- Last name
- FLOWERS
- Relationships
- Director
- Relationship clarification
- [blank]
- Street
- 110 ALLEN ROAD
- Street (continued)
- SECOND FLOOR
- City
- BASKING RIDGE
- State / country code
- NJ
- State / country
- NEW JERSEY
- Postal code
- 07920
Related person 7
- First name
- STEVEN
- Last name
- KLOSK
- Relationships
- Director
- Relationship clarification
- [blank]
- Street
- 110 ALLEN ROAD
- Street (continued)
- SECOND FLOOR
- City
- BASKING RIDGE
- State / country code
- NJ
- State / country
- NEW JERSEY
- Postal code
- 07920
Related person 8
- First name
- MOHAMMAD
- Last name
- AZAB
- Relationships
- Director
- Relationship clarification
- [blank]
- Street
- 110 ALLEN ROAD
- Street (continued)
- SECOND FLOOR
- City
- BASKING RIDGE
- State / country code
- NJ
- State / country
- NEW JERSEY
- Postal code
- 07920
Related person 9
- First name
- TED
- Last name
- LOVE
- Relationships
- Director
- Relationship clarification
- [blank]
- Street
- 110 ALLEN ROAD
- Street (continued)
- SECOND FLOOR
- City
- BASKING RIDGE
- State / country code
- NJ
- State / country
- NEW JERSEY
- Postal code
- 07920
Offering
- Industry
- Biotechnology
- Revenue range
- Decline to Disclose
- Exemption codes
- 06b
- Amendment
- false
- First sale date
- 2026-09-17
- Offering lasts more than one year
- false
- Equity securities
- true
- Option, warrant or other right to acquire a security
- true
- Business combination
- true
- Business combination clarification
- [blank]
- Minimum investment accepted
- 0
- Total offering amount
- 351,903,103
- Amount sold
- 351,903,103
- Remaining amount
- 0
- Amount clarification
- [blank]
- Non-accredited investors reported
- true
- Non-accredited investor count
- 20
- Investors already participating
- 20
Commissions, fees and proceeds
- Sales commissions
- 2,600,000
- Finders’ fees
- 0
- Commission / fee clarification
- [blank]
- Gross proceeds used
- 0
- Use of proceeds clarification
- [blank]
Sales compensation recipient 1
- Name
- H.C.WAINWRIGHT & CO., LLC
- CRD
- 375
- Associated broker-dealer
- None
- Broker-dealer CRD
- None
- Foreign solicitation
- false
- Street
- 430 PARK AVENUE
- Street (continued)
- 4TH FLOOR
- City
- NEW YORK
- State / country code
- NY
- State / country
- NEW YORK
- Postal code
- 10022
- Solicitation jurisdictions
- All States
Sales compensation recipient 2
- Name
- LEERINK PARTNERS LLC
- CRD
- 39011
- Associated broker-dealer
- None
- Broker-dealer CRD
- None
- Foreign solicitation
- false
- Street
- 53 STATE STREET
- Street (continued)
- 40TH FLOOR
- City
- BOSTON
- State / country code
- MA
- State / country
- MASSACHUSETTS
- Postal code
- 02109
- Solicitation jurisdictions
- All States
Sales compensation recipient 3
- Name
- LIFESCI CAPITAL
- CRD
- 168404
- Associated broker-dealer
- None
- Broker-dealer CRD
- None
- Foreign solicitation
- false
- Street
- 1700 BROADWAY
- Street (continued)
- 40TH FLOOR
- City
- NEW YORK
- State / country code
- NY
- State / country
- NEW YORK
- Postal code
- 10019
- Solicitation jurisdictions
- All States
Signature authorization
- Authorized representative
- false
Signature 1
- Issuer
- LISATA THERAPEUTICS, INC.
- Signer
- David Mazzo
- Signed
- /s/ David Mazzo
- Title
- CEO
- Date
- 2026-10-02
Company context
Lisata Therapeutics is a clinical-stage pharmaceutical company. Following its acquisition of Marea Therapeutics, Lisata’s lead product candidate is MAR001, which is in Phase 2b clinical development for the treatment of severe hypertriglyceridemia (sHTG), a condition characterized by very high triglyceride levels. The Company is also advancing MAR002 for the treatment of acromegaly. Lisata’s cyclic peptide product candidate, certepetide, is an investigational drug designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to selectively target and penetrate solid tumors more effectively. For more information on the Company, please visit www.lisata.com.
Current securities
Recent company filings
- ARS filingOct 19, 2026
- DEF 14A filingOct 19, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsOct 14, 2026
- PRE 14A filingOct 7, 2026
- Entry into a Material Definitive Agreement · Completion of Acquisition or Disposition of Assets · Unregistered Sales of Equity Securities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Regulation FD DisclosureSep 17, 2026